There are provided compounds having a superior PHD2 inhibitory effect that are represented by general formula (I′):
(in the above-mentioned general formula (I′),
W, Y, R
2
, R
3
, R
4
, and Y
4
are as described hereinabove), or pharmaceutically acceptable salts thereof.
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.